Guo Yao Liu
Direttore/Membro del Consiglio presso Automatic Result Ltd.
Profilo
Guo Yao Liu is currently a Director at Automatic Result Ltd.
and a Director at Shenzhen Watsin Genetech Ltd.
Previously, he was the Chief Executive Officer & Executive Director at Uni-Bio Science Group Ltd.
from 2011 to 2014.
Posizioni attive di Guo Yao Liu
Società | Posizione | Inizio |
---|---|---|
Automatic Result Ltd.
Automatic Result Ltd. Financial ConglomeratesFinance Part of MJKPC Holdings Ltd., Automatic Result Ltd. is an investment holding There is no available country named vg company. | Direttore/Membro del Consiglio | - |
Shenzhen Watsin Genetech Ltd.
Shenzhen Watsin Genetech Ltd. BiotechnologyHealth Technology Shenzhen Watsin Genetech Ltd. engages in the research, development, manufacture, and sale of biopharmaceutical products and genetic engineering drugs. Its products include genetic engineering products, peptides, recombinant human epidermal growth factor liquid preparation, computer software. The company was founded on April 22, 1997 and is headquartered in Shenzhen, China. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Guo Yao Liu
Società | Posizione | Fine |
---|---|---|
UNI-BIO SCIENCE GROUP LIMITED | Amministratore Delegato | 28/02/2014 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
UNI-BIO SCIENCE GROUP LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Automatic Result Ltd.
Automatic Result Ltd. Financial ConglomeratesFinance Part of MJKPC Holdings Ltd., Automatic Result Ltd. is an investment holding There is no available country named vg company. | Finance |
Shenzhen Watsin Genetech Ltd.
Shenzhen Watsin Genetech Ltd. BiotechnologyHealth Technology Shenzhen Watsin Genetech Ltd. engages in the research, development, manufacture, and sale of biopharmaceutical products and genetic engineering drugs. Its products include genetic engineering products, peptides, recombinant human epidermal growth factor liquid preparation, computer software. The company was founded on April 22, 1997 and is headquartered in Shenzhen, China. | Health Technology |
- Borsa valori
- Insiders
- Guo Yao Liu